تحميل...
CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease [Image: see text]
OBJECTIVE: Cognitive decline associated with Parkinson disease (PD) is common and highly disabling. Biomarkers that help identify patients at risk for cognitive decline would be useful additions to the clinical management of the disease. METHODS: A total of 45 patients with PD were enrolled in this...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
American Academy of Neurology
2010
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2942062/ https://ncbi.nlm.nih.gov/pubmed/20720189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3181f39a78 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|